DA

DA32 Life Science Tech Acquisition CorpNASDAQ DALS Stock Report

Last reporting period 31 Mar, 2023

Updated —

Last price

Market cap $B

0.264

Micro

Exchange

XNAS - Nasdaq

DALS Stock Analysis

DA

Uncovered

DA32 Life Science Tech Acquisition Corp is uncovered by Eyestock quantitative analysis.

Market cap $B

0.264

Dividend yield

Shares outstanding

25.65 B

Da32 Life Science Tech Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search for business combination targets in separate areas of the life sciences industry, including life sciences tools, diagnostics, synthetic biology, and data and analytics platforms. The Company is not engaged in any business operations and has not generated any revenue.

View Section: Eyestock Rating